Peter Emery-Billcliff

Principal Scientist and Lab Manager

Professional Overview
Peter Emery-Billcliff is a seasoned scientist and laboratory manager with a strong background in analytical development, cell and gene therapy, and pharmaceutical R&D. He leverages his technical expertise and leadership skills to drive innovation and excellence in his current role as Principal Scientist and Lab Manager at Complement Therapeutics.

Experience Summary

Current Role
As the Principal Scientist and Lab Manager at Complement Therapeutics, Peter is responsible for overseeing the day-to-day operations of the laboratory, ensuring the highest standards of quality and efficiency. He leads a team of scientists in conducting advanced analytical studies, developing cutting-edge methodologies, and implementing robust quality control measures to support the company's drug development pipeline.

Career Progression
Prior to his current role, Peter held various positions of increasing responsibility at GlaxoSmithKline (GSK), where he contributed significantly to the company's analytical development and cell and gene therapy initiatives. Starting as a Senior Scientist, he progressed to the role of Investigator, leading cross-functional teams and driving the development of novel analytical techniques and processes.

Peter's academic background includes a post-doctoral research position at The University of Manchester, where he honed his scientific expertise and problem-solving skills.

Academic Background
Peter holds a Ph.D. in Pharmaceutical Sciences from The University of Manchester, where he specialized in analytical method development and validation. His academic achievements include several peer-reviewed publications in prestigious scientific journals and recognition for his outstanding research contributions.

Areas of Expertise

• Analytical method development and validation

• Cell and gene therapy product characterization

• Pharmaceutical R&D and quality control

• Laboratory management and team leadership

• Project management and cross-functional collaboration

Professional Impact
During his tenure at GSK, Peter played a pivotal role in the successful development and implementation of cutting-edge analytical techniques for the company's cell and gene therapy pipeline. His innovative approaches and attention to detail have contributed to the advancement of several drug candidates, ultimately benefiting patients in need.

Conclusion
With his extensive experience, strong technical skills, and proven leadership abilities, Peter Emery-Billcliff is a valuable asset to Complement Therapeutics. As the Principal Scientist and Lab Manager, he is well-positioned to drive the company's analytical development efforts, foster a culture of excellence, and contribute to the advancement of novel therapeutic solutions.